Skip to main content
Premium Trial:

Request an Annual Quote

Agilent, MRM Proteomics Extend Co-marketing Agreement

NEW YORK (GenomeWeb) – Agilent Technologies today announced the extension of a co-marketing agreement with MRM Proteomics.

The extension expands a deal between the companies reached in September 2012, and will allow the partners to improve their combined proteomics solutions comprising reagents kits, hardware, and software, Agilent said.

Based in Vancouver, British Columbia, MRM Proteomics offers protein quantitation, biomarker, and proteomics services to drug manufacturers, biotech, and diagnostics customers. It recently named Gary Krupp as its CEO as it continues its efforts to bring MALDI-TOF-based protein assays to the clinic.

The Scan

Call for a Different Tack

Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News.

Wastewater Warning

The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge.

Can't Get in the Program

Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports.

Science Paper on Spatial-Controlled Genome Editing

In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.